Elsevier

The Lancet

Volume 332, Issue 8614, 1 October 1988, Pages 755-759
The Lancet

CIRCADIAN VARIATION OF TOTAL ISCHAEMIC BURDEN AND ITS ALTERATION WITH ANTI-ANGINAL AGENTS

https://doi.org/10.1016/S0140-6736(88)92414-2Get rights and content

Abstract

6264 hours of ambulatory ST segment monitoring of 150 unselected patients with proven coronary artery disease, who were off all routine anti-anginal treatments, showed 598 ischaemic episodes, of which 446 (75%) were silent (symptom-free). Most (68%) ischaemic episodes occurred between 0730 and 1930, with a peak in the morning and a lesser peak in the evening. Two subgroups were studied further in double-blind controlled trials: 33 patients had a total of 1313 hours of ST segment monitoring while treated with nifedipine; and 41 patients a total of 1581 hours while treated with atenolol. Nifedipine did not alter the circadian pattern of ischaemic episodes; atenolol abolished the morning peak, and the peak incidence of ischaemia then occurred in the evening. Circadian patterns for total duration of ischaemic episodes corresponded closely to those of episodes of ischaemia, and were similarly altered by treatment. The circadian pattern of silent ischaemic episodes and their total duration were very similar to those of total ischaemia for the group as a whole and the different subgroups. This circadian distribution of ischaemic episodes and the observed changes with treatment resemble the reported circadian variation of acute myocardial infarction and sudden death.

References (8)

There are more references available in the full text version of this article.

Cited by (293)

  • Sleep disorders, nocturnal blood pressure, and cardiovascular risk: A translational perspective

    2019, Autonomic Neuroscience: Basic and Clinical
    Citation Excerpt :

    Increased nighttime variability of ABP and increased nighttime values of HR may also contribute to subclinical CV organ damage (Cuspidi et al., 2018; Stamatelopoulos et al., 2010). Sleep-related disorders may increase the occurrence of CVD events by causing increases in nighttime CV activity large enough to convert the nighttime sleep period from a period of relative protection against CVD events (Marler et al., 1989; Mulcahy et al., 1988; Muller et al., 1989; Reavey et al., 2013; Willich et al., 1987) to one of enhanced risk. In particular, the wide and repeated CV fluctuations associated with apneas during the night in subjects with OSA may provide conditions of significant hemodynamic stress and autonomic activity, favoring vulnerable plaque rupture and malignant arrhythmias (Somers et al., 1995).

  • Circadian Variation of Death in Hemodialysis Patients

    2008, American Journal of Kidney Diseases
    Citation Excerpt :

    Jones-Crawford et al,25 in their recent retrospective analysis of in-hospital cardiopulmonary arrests, found no clear circadian distribution of events. β-Blocker use repeatedly was associated with absent or blunted circadian occurrence of cardiac morbid events in susceptible individuals.8,26,27 In our study, the association of β-blocker use with increased morning risk of death in prevalent dialysis patients extends the observation of Bleyer et al,13 who found that hemodialysis patients who died in the interval 60 to 72 hours after dialysis treatment were more likely to be on β-blocker therapy.

View all citing articles on Scopus
View full text